Related Experiment Video
Updated: Sep 28, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[Selectivity of the reverse transcriptase inhibitors toward types 1 and 2 of human immunodeficiency virus (HIV)]
J M J Tronchet1, C Apparu-Turquois, N Laroze
1Laboratoires CPOP, Section de Pharmacie, Faculté des Sciences, Université de Genève Sciences 2 CH-1211 Genève 4, Switzerland..
Abstract:
Two novel series of acyclonucleosides active as nonnucleoside reverse transcriptase inhibitors (NNRTI) against the human immunodeficiency virus (HIV) have been synthesized. Structural modifications, inverting the selectivity of classical NNRTI, considerably more active against HIV-1 than HIV-2, are reported. In these series, an increase in anti-HIV-2 activity is correlated with an increase of the cytotoxicity of these new molecules.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Viruses with RNA Genomes
Size and Structure of Viral Genomes
Inhibitors Of Virion Release